Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
Even before Nvidia Corp.’s splashy $500 billion financing partnership this week, investors were starting to fret over the roughly $70 billion in phantom liabilities that don’t appear on major AI companies’ balance sheets, but could materialize at the worst possible time.
Goldman Sachs expects corporate share repurchases to remain a powerful source of demand for U. S.
Anthropic PBC is telling prospective investors its second-quarter revenue jumped at least 14-fold versus the same period a year ago, according to documents seen by Bloomberg News.
“Boomer candy” funds got the name because they appeal to retirees. Goldman Sachs sees opportunity and acquires ETF company Neos.
Two AI chip giants moved in opposite directions Friday as Wall Street put a massive dollar figure on a financing structure that Broadcom and Nvidia both use, raising questions about which companies benefit from AI's debt-fueled buildout and which carry the hidden risk.
Goldman Sachs' four mutual funds offer diversified exposure and strong returns across international, small-cap, large-cap growth and dividend stocks.
Goldman Sachs said the transaction would add to its range of derivative-based ETF products.
Independent financing platforms could broaden access to NVIDIA systems without requiring the chipmaker to supply all the capital itself.
Goldman Sachs Group will pay as much as $2.25 billion to buy Neos Investments, expanding its asset manager's reach in the actively managed ETF market. Katherine Doherty reports on "Bloomberg Open Interest."
Could GS's M&A leadership, record investment-banking backlog and AI push fuel further growth? Let us find out.
DICK'S Sporting, Motorola and Goldman stand out for accelerating sales growth, strong cash flow and favorable valuation and profitability metrics.
Nvidia confirmed on Monday that it will partner with some of the world's largest financial companies on a $500 billion financing effort to build out artificial intelligence infrastructure. Nvidia will work with Apollo Global Management, Blackstone and Goldman Sachs "to mobilize over $500 billion of third-party capital for the buildout of AI infrastructure over time," a news release said.
The US-based financial institution worked on three transactions with a combined value of $34.8bn.
(Bloomberg) -- Latigo Biotherapeutics Inc., a clinical-stage developer of non-opioid pain medicines, climbed 17% on Friday after raising $345.6 million in an upsized initial public offering, priced at the top of a marketed range.Most Read from BloombergOpenAI’s New Device Will Be Hockey Puck-Sized and Cost Over $300Iran Wants to Bar US, Israeli Ships From Hormuz in Peace AccordIran Says Agreement on Hormuz Shipping Reached With OmanTrump Administration Considers Order on Autism and VaccinesWhy D
Here is how Goldman Sachs (GS) and Ategrity Specialty Insurance Company Holdings (ASIC) have performed compared to their sector so far this year.
Data from GlobalData’s Financial Deals Database shows the bank worked on three transactions with a combined value of $10.4bn.
Stock Market Today: The Dow Jones index rises, while tech futures drop as AI stocks Sandisk and Western Digital plunge on earnings.
Goldman Sachs just named a specific Kospi target that would make South Korean equities among the biggest winning trades of the decade, but it hinges on two chip giants delivering something the market has never quite seen before.
FIX, GS, VRT, STX and TRV are five momentum stocks for August as AI infrastructure, financial strength and earnings growth support their outlooks.
Goldman Sachs Group (NYSE:GS) premium income ETFs, GPIX and GPIQ, are currently outperforming JPMorgan’s JEPI and JEPQ across expense ratios, dividend yields, and total returns. The comparison highlights competitive advantages for Goldman Sachs products in the premium income ETF category. The performance gap has drawn attention to Goldman Sachs as a growing player in retail income-focused ETFs. Goldman Sachs Group has long been known for its institutional and advisory businesses, and its...
(Bloomberg) -- The momentum trade just gave investors a taste of the pronounced profit-and-loss swings they can expect if they fail to hedge or diversify, a warning that’s reinforced by growing inflation risks. Most Read from BloombergTrump Says US to Hold Off Iran Attack If Deal AgreedSaudi Prince Concerned Over Trump’s Iran Strike Plan: AxiosTrump Says Iran Talks to Begin Monday After Scrapping AttackSingapore's Gated Island for the Rich Is Marred by Decayed HomesAlibaba Adds to China AI Break
Apple just posted its strongest June quarter ever and surged double digits, yet one popular income ETF built around Nasdaq-100 giants moved in the opposite direction. Understanding why reveals a hidden cost that never appears on the fund's expense-ratio line.
Financial stocks like XLF, JPMorgan, and Bank of America hit new highs on strong Q2 earnings as investors rotate out of technology, though bank shares pulled back ahead of the Fed meeting.
Financial stocks have been among the market’s best performers this month. The Fed’s next move, however, may determine how much further the rotation can run.
Robinhood Markets (Nasdaq: HOOD) reported its earnings for the second quarter of 2026 on July 29. The brokerage platform, popular for its equity, crypto, and tokenized stock offerings, generated $1.31 billion in revenue and $0.62 in earnings per share (EPS), beating Wall ...
Goldman Sachs advised on transactions worth $437.7bn, while Houlihan Lokey ranked first by volume with 104 deals.
Goldman Sachs Group (NYSE:GS) has launched a new private markets platform aimed at wealthy clients, expanding access to alternative investments. Goldman Sachs Alternatives has agreed to acquire AEGIS Hedging Solutions, a provider of risk management and hedging services. For investors watching how Goldman Sachs Group positions itself beyond traditional investment banking, these two moves sit squarely in its asset and wealth management efforts. A broader private markets platform for high net...
Alphabet, MasTec and Goldman Sachs topped a momentum screen built on the Driehaus strategy, combining earnings strength with favorable price trends.
(Bloomberg) -- Scribe Therapeutics Inc., a clinical-stage developer of gene therapies for heart diseases, surged 67% on Friday after raising $128.7 million in an upsized initial public offering.Most Read from BloombergRetina Chip Designed to Restore Sight to Go on Sale in EuropeHegseth Turns to UNC, Virginia Tech After Dropping Ivy LeagueApple Plans Overhaul of MacBooks, iMac in Push to Meet AI DemandTrump Rebuilds Tariffs With New Levies on 60 EconomiesSpaceX Turns Away Falcon Customers in Majo
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
